Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review
Background: Radiation therapy has been progressively improved in order to maintain a satisfactory tumour response, while reducing toxicity. We will review the incidence of radiodermatitis and fibrosis according to the various radiation and fractionation techniques. We will then focus on the various...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-11-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/13/23/5928 |
| _version_ | 1797507999501123584 |
|---|---|
| author | Sofiane Allali Youlia Kirova |
| author_facet | Sofiane Allali Youlia Kirova |
| author_sort | Sofiane Allali |
| collection | DOAJ |
| description | Background: Radiation therapy has been progressively improved in order to maintain a satisfactory tumour response, while reducing toxicity. We will review the incidence of radiodermatitis and fibrosis according to the various radiation and fractionation techniques. We will then focus on the various methods used to manage, prevent, and quantify this toxicity. Method: More than 1753 articles were identified using the various search terms. We selected 53 articles to answer the questions addressed in this study according to criteria set in advance. Result: The literature reports lower acute toxicity with IMRT compared to 3DCRT, but no significant differences in terms of late toxicities. Partial breast irradiation appears to be less effective in terms of local control with a higher rate of late toxicity. Intra operative radiation therapy appears to provide good results in terms of both local control and late toxicity. The hypofractionation has equivalent efficacy and safety to the normofractionated regimen, but with lower rates of radiodermatitis and fibrosis. The adddition of a boost, particularly a sequential boost, increases the risk of fibrosis and radiodermatitis during treatment. Conclusion: The development of IMRT has significantly reduced acute toxicity and has improved tolerability during treatment. Modified fractionation has reduced treatment time, as well as adverse effects. |
| first_indexed | 2024-03-10T04:56:23Z |
| format | Article |
| id | doaj.art-97392e6317c54045975660be72d80a7d |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-10T04:56:23Z |
| publishDate | 2021-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-97392e6317c54045975660be72d80a7d2023-11-23T02:11:36ZengMDPI AGCancers2072-66942021-11-011323592810.3390/cancers13235928Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical ReviewSofiane Allali0Youlia Kirova1Radiation Therapy Department, Institut Curie, CEDEX 05, 75248 Paris, FranceRadiation Therapy Department, Institut Curie, CEDEX 05, 75248 Paris, FranceBackground: Radiation therapy has been progressively improved in order to maintain a satisfactory tumour response, while reducing toxicity. We will review the incidence of radiodermatitis and fibrosis according to the various radiation and fractionation techniques. We will then focus on the various methods used to manage, prevent, and quantify this toxicity. Method: More than 1753 articles were identified using the various search terms. We selected 53 articles to answer the questions addressed in this study according to criteria set in advance. Result: The literature reports lower acute toxicity with IMRT compared to 3DCRT, but no significant differences in terms of late toxicities. Partial breast irradiation appears to be less effective in terms of local control with a higher rate of late toxicity. Intra operative radiation therapy appears to provide good results in terms of both local control and late toxicity. The hypofractionation has equivalent efficacy and safety to the normofractionated regimen, but with lower rates of radiodermatitis and fibrosis. The adddition of a boost, particularly a sequential boost, increases the risk of fibrosis and radiodermatitis during treatment. Conclusion: The development of IMRT has significantly reduced acute toxicity and has improved tolerability during treatment. Modified fractionation has reduced treatment time, as well as adverse effects.https://www.mdpi.com/2072-6694/13/23/5928radiation therapybreast cancerskin toxicitiesfibrosisradiodermatitisradiotherapy |
| spellingShingle | Sofiane Allali Youlia Kirova Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review Cancers radiation therapy breast cancer skin toxicities fibrosis radiodermatitis radiotherapy |
| title | Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review |
| title_full | Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review |
| title_fullStr | Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review |
| title_full_unstemmed | Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review |
| title_short | Radiodermatitis and Fibrosis in the Context of Breast Radiation Therapy: A Critical Review |
| title_sort | radiodermatitis and fibrosis in the context of breast radiation therapy a critical review |
| topic | radiation therapy breast cancer skin toxicities fibrosis radiodermatitis radiotherapy |
| url | https://www.mdpi.com/2072-6694/13/23/5928 |
| work_keys_str_mv | AT sofianeallali radiodermatitisandfibrosisinthecontextofbreastradiationtherapyacriticalreview AT youliakirova radiodermatitisandfibrosisinthecontextofbreastradiationtherapyacriticalreview |